STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more

The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk

NHS gets £500m boost in Wales' first budget under Plaid Cymru

NIH’s infectious disease unit has a new head at last

STAT+: With $173 million, new startup takes aim at sickle cell

I'm a human doctor with human intelligence. But I sure do like my AI notetaker

More people are getting the flu. Should you get a flu shot before you travel?
